Min Tao, Margaret A. McDowell, Sharon H. Saydah, and Mark S. EberhardtRelationship of Polyunsaturated Fatty Acid Intake to Peripheral Neuropathy Among Adults With Diabetes in the National Health and Nutrition Examination Survey (NHANES) 1999–2004. Diabetes Care 2008 31: 93–95 Abstract
doi.org
dx.doi.org
C. Bénistant, F. Achard, S. Ben Slama, M. Lagarde: Docosapentaenoic acid (22:5,n-3): metabolism and effect on prostacyclin production in endothelial cells. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 1996-10, 55. vsk, nro 4, s. 287–292. PubMed:8951998doi:10.1016/s0952-3278(96)90010-1ISSN 0952-3278Artikkelin verkkoversio.
Scientific Opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and maintenance of normal cardiac function (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325), maintenance of normal blood glucose concentrations (ID 566), maintenance of normal blood pressure (ID 506, 516, 703, 1317, 1324), maintenance of normal blood HDL-cholesterol concentrations (ID 506), maintenance of normal (fasting) blood concentrations of triglycerides (ID 506, 527, 538, 1317, 1324, 1325), maintenance of normal blood LDL-cholesterol concentrations (ID 527, 538, 1317, 1325, 4689), protection of the skin from photo-oxidative (UV-induced) damage (ID 530), improved absorption of EPA and DHA (ID 522, 523), contribution to the normal function of the immune system by decreasing the levels of eicosanoids, arachidonic acid-derived mediators and pro-inflammatory cytokines (ID 520, 2914), and “immunomodulating agent” (4690) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 2010, nro 8, s. 1796. doi:10.2903/j.efsa.2010.1796ISSN 1831-4732Artikkelin verkkoversio. (englanti)
Theingi Aung, Jim Halsey, Daan Kromhout, Hertzel C. Gerstein, Roberto Marchioli, Luigi Tavazzi: Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. JAMA Cardiology, 1.3.2018, nro 3, s. 225–233. doi:10.1001/jamacardio.2017.5205ISSN 2380-6583Artikkelin verkkoversio.
Rajiv Chowdhury ym.: Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk. Annals of Internal Medicine, 18.3.2014, nro 6. doi:10.7326/m13-1788ISSN 0003-4819Artikkelin verkkoversio. (englanniksi)
Joshua T. Cohen, David C. Bellinger, William E. Connor, Bennett A. Shaywitz: A Quantitative Analysis of Prenatal Intake of n-3 Polyunsaturated Fatty Acids and Cognitive Development. American Journal of Preventive Medicine, 1.11.2005, 29. vsk, nro 4, s. 366–366.e12. doi:10.1016/j.amepre.2005.06.008ISSN 0749-3797Artikkelin verkkoversio.
Kaylee E. Hahn, Irina Dahms, Christopher M. Butt, Norman Salem, Vivian Grimshaw, Eileen Bailey, Stephen A. Fleming, Brooke N. Smith, Ryan N. Dilger: Impact of Arachidonic and Docosahexaenoic Acid Supplementation on Neural and Immune Development in the Young Pig. Frontiers in Nutrition, 2020, 7. vsk. doi:10.3389/fnut.2020.592364/fullISSN 2296-861XArtikkelin verkkoversio.
Joshua T. Cohen, David C. Bellinger, William E. Connor, Bennett A. Shaywitz: A Quantitative Analysis of Prenatal Intake of n-3 Polyunsaturated Fatty Acids and Cognitive Development. American Journal of Preventive Medicine, 1.11.2005, 29. vsk, nro 4, s. 366–366.e12. doi:10.1016/j.amepre.2005.06.008ISSN 0749-3797Artikkelin verkkoversio.
Daniel G. Amen, William S. Harris, Parris M. Kidd, Somayeh Meysami, Cyrus A. Raji: Quantitative Erythrocyte Omega-3 EPA Plus DHA Levels are Related to Higher Regional Cerebral Blood Flow on Brain SPECT. Journal of Alzheimer's disease: JAD, 2017, nro 4, s. 1189–1199. PubMed:28527220doi:10.3233/JAD-170281ISSN 1875-8908Artikkelin verkkoversio.
Theingi Aung, Jim Halsey, Daan Kromhout, Hertzel C. Gerstein, Roberto Marchioli, Luigi Tavazzi: Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. JAMA Cardiology, 1.3.2018, nro 3, s. 225–233. doi:10.1001/jamacardio.2017.5205ISSN 2380-6583Artikkelin verkkoversio.
Kaylee E. Hahn, Irina Dahms, Christopher M. Butt, Norman Salem, Vivian Grimshaw, Eileen Bailey, Stephen A. Fleming, Brooke N. Smith, Ryan N. Dilger: Impact of Arachidonic and Docosahexaenoic Acid Supplementation on Neural and Immune Development in the Young Pig. Frontiers in Nutrition, 2020, 7. vsk. doi:10.3389/fnut.2020.592364/fullISSN 2296-861XArtikkelin verkkoversio.
C. Bénistant, F. Achard, S. Ben Slama, M. Lagarde: Docosapentaenoic acid (22:5,n-3): metabolism and effect on prostacyclin production in endothelial cells. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 1996-10, 55. vsk, nro 4, s. 287–292. PubMed:8951998doi:10.1016/s0952-3278(96)90010-1ISSN 0952-3278Artikkelin verkkoversio.
Daniel G. Amen, William S. Harris, Parris M. Kidd, Somayeh Meysami, Cyrus A. Raji: Quantitative Erythrocyte Omega-3 EPA Plus DHA Levels are Related to Higher Regional Cerebral Blood Flow on Brain SPECT. Journal of Alzheimer's disease: JAD, 2017, nro 4, s. 1189–1199. PubMed:28527220doi:10.3233/JAD-170281ISSN 1875-8908Artikkelin verkkoversio.
van Woudenbergh GJ, van Ballegooijen AJ, Kuijsten A, Sijbrands EJ, van Rooij FJ, Geleijnse JM, Hofman A, Witteman JC, Feskens EJ.: Eating fish and risk of type 2 diabetes: A population-based, prospective follow-up study. Diabetes Care, Epub 2009 Aug 12 Numero = 32(11), s. 2021–2026. Artikkelin verkkoversio. Viitattu 24.3.2010. (englanniksi)
Rajiv Chowdhury ym.: Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk. Annals of Internal Medicine, 18.3.2014, nro 6. doi:10.7326/m13-1788ISSN 0003-4819Artikkelin verkkoversio. (englanniksi)
Do fatty acids help in overcoming reading difficulties?. A double-blind, placebo-controlled study of the effects of eicosapentaenoic acid and carnosine supplementation on children with dyslexia. Child Care Health and Development 35(1):112-9. January 2009.
Joshua T. Cohen, David C. Bellinger, William E. Connor, Bennett A. Shaywitz: A Quantitative Analysis of Prenatal Intake of n-3 Polyunsaturated Fatty Acids and Cognitive Development. American Journal of Preventive Medicine, 1.11.2005, 29. vsk, nro 4, s. 366–366.e12. doi:10.1016/j.amepre.2005.06.008ISSN 0749-3797Artikkelin verkkoversio.
Joshua T. Cohen, David C. Bellinger, William E. Connor, Bennett A. Shaywitz: A Quantitative Analysis of Prenatal Intake of n-3 Polyunsaturated Fatty Acids and Cognitive Development. American Journal of Preventive Medicine, 1.11.2005, 29. vsk, nro 4, s. 366–366.e12. doi:10.1016/j.amepre.2005.06.008ISSN 0749-3797Artikkelin verkkoversio.
Scientific Opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and maintenance of normal cardiac function (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325), maintenance of normal blood glucose concentrations (ID 566), maintenance of normal blood pressure (ID 506, 516, 703, 1317, 1324), maintenance of normal blood HDL-cholesterol concentrations (ID 506), maintenance of normal (fasting) blood concentrations of triglycerides (ID 506, 527, 538, 1317, 1324, 1325), maintenance of normal blood LDL-cholesterol concentrations (ID 527, 538, 1317, 1325, 4689), protection of the skin from photo-oxidative (UV-induced) damage (ID 530), improved absorption of EPA and DHA (ID 522, 523), contribution to the normal function of the immune system by decreasing the levels of eicosanoids, arachidonic acid-derived mediators and pro-inflammatory cytokines (ID 520, 2914), and “immunomodulating agent” (4690) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 2010, nro 8, s. 1796. doi:10.2903/j.efsa.2010.1796ISSN 1831-4732Artikkelin verkkoversio. (englanti)
C. Bénistant, F. Achard, S. Ben Slama, M. Lagarde: Docosapentaenoic acid (22:5,n-3): metabolism and effect on prostacyclin production in endothelial cells. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 1996-10, 55. vsk, nro 4, s. 287–292. PubMed:8951998doi:10.1016/s0952-3278(96)90010-1ISSN 0952-3278Artikkelin verkkoversio.
Scientific Opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and maintenance of normal cardiac function (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325), maintenance of normal blood glucose concentrations (ID 566), maintenance of normal blood pressure (ID 506, 516, 703, 1317, 1324), maintenance of normal blood HDL-cholesterol concentrations (ID 506), maintenance of normal (fasting) blood concentrations of triglycerides (ID 506, 527, 538, 1317, 1324, 1325), maintenance of normal blood LDL-cholesterol concentrations (ID 527, 538, 1317, 1325, 4689), protection of the skin from photo-oxidative (UV-induced) damage (ID 530), improved absorption of EPA and DHA (ID 522, 523), contribution to the normal function of the immune system by decreasing the levels of eicosanoids, arachidonic acid-derived mediators and pro-inflammatory cytokines (ID 520, 2914), and “immunomodulating agent” (4690) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA Journal, 2010, nro 8, s. 1796. doi:10.2903/j.efsa.2010.1796ISSN 1831-4732Artikkelin verkkoversio. (englanti)
Theingi Aung, Jim Halsey, Daan Kromhout, Hertzel C. Gerstein, Roberto Marchioli, Luigi Tavazzi: Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals. JAMA Cardiology, 1.3.2018, nro 3, s. 225–233. doi:10.1001/jamacardio.2017.5205ISSN 2380-6583Artikkelin verkkoversio.
Rajiv Chowdhury ym.: Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk. Annals of Internal Medicine, 18.3.2014, nro 6. doi:10.7326/m13-1788ISSN 0003-4819Artikkelin verkkoversio. (englanniksi)
Joshua T. Cohen, David C. Bellinger, William E. Connor, Bennett A. Shaywitz: A Quantitative Analysis of Prenatal Intake of n-3 Polyunsaturated Fatty Acids and Cognitive Development. American Journal of Preventive Medicine, 1.11.2005, 29. vsk, nro 4, s. 366–366.e12. doi:10.1016/j.amepre.2005.06.008ISSN 0749-3797Artikkelin verkkoversio.
Kaylee E. Hahn, Irina Dahms, Christopher M. Butt, Norman Salem, Vivian Grimshaw, Eileen Bailey, Stephen A. Fleming, Brooke N. Smith, Ryan N. Dilger: Impact of Arachidonic and Docosahexaenoic Acid Supplementation on Neural and Immune Development in the Young Pig. Frontiers in Nutrition, 2020, 7. vsk. doi:10.3389/fnut.2020.592364/fullISSN 2296-861XArtikkelin verkkoversio.
Joshua T. Cohen, David C. Bellinger, William E. Connor, Bennett A. Shaywitz: A Quantitative Analysis of Prenatal Intake of n-3 Polyunsaturated Fatty Acids and Cognitive Development. American Journal of Preventive Medicine, 1.11.2005, 29. vsk, nro 4, s. 366–366.e12. doi:10.1016/j.amepre.2005.06.008ISSN 0749-3797Artikkelin verkkoversio.
Daniel G. Amen, William S. Harris, Parris M. Kidd, Somayeh Meysami, Cyrus A. Raji: Quantitative Erythrocyte Omega-3 EPA Plus DHA Levels are Related to Higher Regional Cerebral Blood Flow on Brain SPECT. Journal of Alzheimer's disease: JAD, 2017, nro 4, s. 1189–1199. PubMed:28527220doi:10.3233/JAD-170281ISSN 1875-8908Artikkelin verkkoversio.